Animal Biotechnology Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global animal biotechnology market looks promising with opportunities in the development of animal pharmaceuticals, food safety and drug development, diagnosis of animal diseases, treatment of animal diseases, and preventive care of animals. The global animal biotechnology market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major growth drivers for this market are increasing regulatory approvals and increase in research and development activities related to animal biotechnology.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global animal biotechnology market report, please download the report brochure.
In this market, vaccine is the fastest growing product type of animal biotechnology, whereas development of animal biopharmaceutical is the fastest growing application. Growth in various segments of the animal biotechnology market are given below:
The study includes trends and forecast for the global animal biotechnology market by product, application, animal type, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
KitsReproductive and Genetic ProductsVaccinesDrugs
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Development of Animal PharmaceuticalsFood Safety and Drug DevelopmentDiagnosis and Animal DiseasesTreatment of Animal DiseasesPreventive Care of AnimalsOthers
By Animal Type [Value ($ Million) shipment analysis for 2014 – 2025]:
LivestockBovinePorcineOvinePoultryOthersCompanionCanineFelineEquineAquaticAvianOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the animal biotechnology companies profiled in this report include Bayer, Merck & Co., Pfizer, Boehringer Ingelheim, Virbac, Zoetis, Sanofi, Intervet, Santa Cruz Biotechnology, and Biogenesis Bago.
Lucintel forecasts that the vaccine will remain the highest growing product type over the forecast period due to rising animal diseases and increasing adoption of pets.
Within this market, animal biotechnology for development of animal pharmaceutical will remain the fastest growing application over the forecast period due to increasing awareness of pet owners towards animal health.
North America will remain the largest market over the forecast period due to rising per capita expenditure on animal health, rising government support, and increasing animal meat consumption.
Features of the Global Animal Biotechnology Market
Market Size Estimates: Global animal biotechnology market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global animal biotechnology market size by various segments, such as product, application, and animal type in terms of value.Regional Analysis: Global animal biotechnology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, animal type, and region for the global animal biotechnology market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global animal biotechnology market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global animal biotechnology market by product (kits, reproductive and genetic products, vaccines, and drugs), application (development of animal pharmaceuticals, food safety and drug development, diagnosis and animal diseases, treatment of animal diseases, preventive care of animals, and others), animal type ((livestock (bovine, porcine, ovine, poultry, and others) and companion (canine, feline, equine, aquatic, avian, and others)), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global animal biotechnology market?
Q.5 What are the business risks and threats to the global animal biotechnology market?
Q.6 What are the emerging trends in this animal biotechnology market and the reasons behind them?
Q.7 What are some changing demands of customers in this animal biotechnology market?
Q.8 What are the new developments in this animal biotechnology market? Which companies are leading these developments?
Q.9 Who are the major players in this animal biotechnology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this animal biotechnology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global animal biotechnology market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits, Reproductive and Genetic Products, Vaccines, and Drugs), Application (Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis and Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others), and Animal Type (Livestock and Companion)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global animal biotechnology market looks promising with opportunities in the development of animal pharmaceuticals, food safety and drug development, diagnosis of animal diseases, treatment of animal diseases, and preventive care of animals. The global animal biotechnology market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major growth drivers for this market are increasing regulatory approvals and increase in research and development activities related to animal biotechnology.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global animal biotechnology market report, please download the report brochure.
In this market, vaccine is the fastest growing product type of animal biotechnology, whereas development of animal biopharmaceutical is the fastest growing application. Growth in various segments of the animal biotechnology market are given below:
The study includes trends and forecast for the global animal biotechnology market by product, application, animal type, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
KitsReproductive and Genetic ProductsVaccinesDrugs
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Development of Animal PharmaceuticalsFood Safety and Drug DevelopmentDiagnosis and Animal DiseasesTreatment of Animal DiseasesPreventive Care of AnimalsOthers
By Animal Type [Value ($ Million) shipment analysis for 2014 – 2025]:
LivestockBovinePorcineOvinePoultryOthersCompanionCanineFelineEquineAquaticAvianOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the animal biotechnology companies profiled in this report include Bayer, Merck & Co., Pfizer, Boehringer Ingelheim, Virbac, Zoetis, Sanofi, Intervet, Santa Cruz Biotechnology, and Biogenesis Bago.
Lucintel forecasts that the vaccine will remain the highest growing product type over the forecast period due to rising animal diseases and increasing adoption of pets.
Within this market, animal biotechnology for development of animal pharmaceutical will remain the fastest growing application over the forecast period due to increasing awareness of pet owners towards animal health.
North America will remain the largest market over the forecast period due to rising per capita expenditure on animal health, rising government support, and increasing animal meat consumption.
Features of the Global Animal Biotechnology Market
Market Size Estimates: Global animal biotechnology market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global animal biotechnology market size by various segments, such as product, application, and animal type in terms of value.Regional Analysis: Global animal biotechnology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, application, animal type, and region for the global animal biotechnology market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global animal biotechnology market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global animal biotechnology market by product (kits, reproductive and genetic products, vaccines, and drugs), application (development of animal pharmaceuticals, food safety and drug development, diagnosis and animal diseases, treatment of animal diseases, preventive care of animals, and others), animal type ((livestock (bovine, porcine, ovine, poultry, and others) and companion (canine, feline, equine, aquatic, avian, and others)), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global animal biotechnology market?
Q.5 What are the business risks and threats to the global animal biotechnology market?
Q.6 What are the emerging trends in this animal biotechnology market and the reasons behind them?
Q.7 What are some changing demands of customers in this animal biotechnology market?
Q.8 What are the new developments in this animal biotechnology market? Which companies are leading these developments?
Q.9 Who are the major players in this animal biotechnology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this animal biotechnology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global animal biotechnology market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits, Reproductive and Genetic Products, Vaccines, and Drugs), Application (Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis and Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others), and Animal Type (Livestock and Companion)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends (2014-2019) and Forecast (2020-2025)
3.2: Global Animal Biotechnology Market Trends (2014-2019) and Forecast (2020-2025)
3.3: Global Animal Biotechnology Market by Product
3.3.1: Kits
3.3.2: Reproductive and Genetic Products
3.3.3: Vaccines
3.3.4: Drugs
3.4: Global Animal Biotechnology Market by Application
3.4.1: Development of Animal Pharmaceuticals
3.4.2: Food Safety and Drug Development
3.4.3: Diagnosis of Animal Diseases
3.4.4: Treatment of Animal Diseases
3.4.5: Preventive Care of Animals
3.4.6: Others
3.5: Global Animal Biotechnology Market by Animal Type
3.5.1: Livestock
3.5.1.1: Bovine
3.5.1.2: Porcine
3.5.1.3: Ovine
3.5.1.4: Poultry
3.5.1.5: Others
3.5.2: Companion
3.5.2.1: Canine
3.5.2.2: Feline
3.5.2.3: Equine
3.5.2.4: Aquatic
3.5.2.5: Avian
3.5.2.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025 BY REGION
4.1: Global Animal Biotechnology Market by Region
4.2: North American Animal Biotechnology Market
4.2.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.2.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others
4.2.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.2.4: The United States Animal Biotechnology Market
4.2.5: The Canadian Animal Biotechnology Market
4.2.6: The Mexican Animal Biotechnology Market
4.3: European Animal Biotechnology Market
4.3.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.3.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others.
4.3.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.3.4: The Animal Biotechnology Market of United Kingdom
4.3.5: The German Animal Biotechnology Market
4.3.6: The France Animal Biotechnology Market
4.4: APAC Animal Biotechnology Market
4.4.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.4.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others
4.4.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.4.4: Chinese Animal Biotechnology Market
4.4.5: Indian Animal Biotechnology Market.
4.4.6: Japanese Animal Biotechnology Market
4.5: ROW Animal Biotechnology Market
4.5.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.5.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others
4.5.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.5.4: Brazilian Animal Biotechnology Market
5. COMPETITOR ANALYSIS
5.1: Product Portfoli Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Animal Biotechnology Market by Product
7.1.2: Growth Opportunities for the Global Animal Biotechnology Market by Application
7.1.3: Growth Opportunities for the Global Animal Biotechnology Market by Animal Type
7.1.4: Growth Opportunities for the Global Animal Biotechnology Market by Region
7.2: Emerging Trends in the Global Animal Biotechnology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Animal Biotechnology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Animal Biotechnology Market
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Bayer AG
8.2: Merck & Co.
8.3: Pfizer
8.4: Boehringer Ingelheim
8.5: Virbac
8.6: Zoetis
8.7: Intervet
8.8: Santa Cruz Biotechnology, Inc.
8.9: Biogenesis Bag
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends (2014-2019) and Forecast (2020-2025)
3.2: Global Animal Biotechnology Market Trends (2014-2019) and Forecast (2020-2025)
3.3: Global Animal Biotechnology Market by Product
3.3.1: Kits
3.3.2: Reproductive and Genetic Products
3.3.3: Vaccines
3.3.4: Drugs
3.4: Global Animal Biotechnology Market by Application
3.4.1: Development of Animal Pharmaceuticals
3.4.2: Food Safety and Drug Development
3.4.3: Diagnosis of Animal Diseases
3.4.4: Treatment of Animal Diseases
3.4.5: Preventive Care of Animals
3.4.6: Others
3.5: Global Animal Biotechnology Market by Animal Type
3.5.1: Livestock
3.5.1.1: Bovine
3.5.1.2: Porcine
3.5.1.3: Ovine
3.5.1.4: Poultry
3.5.1.5: Others
3.5.2: Companion
3.5.2.1: Canine
3.5.2.2: Feline
3.5.2.3: Equine
3.5.2.4: Aquatic
3.5.2.5: Avian
3.5.2.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025 BY REGION
4.1: Global Animal Biotechnology Market by Region
4.2: North American Animal Biotechnology Market
4.2.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.2.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others
4.2.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.2.4: The United States Animal Biotechnology Market
4.2.5: The Canadian Animal Biotechnology Market
4.2.6: The Mexican Animal Biotechnology Market
4.3: European Animal Biotechnology Market
4.3.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.3.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others.
4.3.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.3.4: The Animal Biotechnology Market of United Kingdom
4.3.5: The German Animal Biotechnology Market
4.3.6: The France Animal Biotechnology Market
4.4: APAC Animal Biotechnology Market
4.4.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.4.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others
4.4.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.4.4: Chinese Animal Biotechnology Market
4.4.5: Indian Animal Biotechnology Market.
4.4.6: Japanese Animal Biotechnology Market
4.5: ROW Animal Biotechnology Market
4.5.1: Market by Product: Kits, Reproductive and Genetic Products, Vaccines, and Drugs
4.5.2: Market by Application: Development of Animal Pharmaceuticals, Food Safety and Drug Development, Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, and Others
4.5.3: Market by Animal Type: Livestock (Bovine, Porcine, Ovine, Poultry, and Others) and Companion (Canine, Feline, Equine, Aquatic, Avian, and Others)
4.5.4: Brazilian Animal Biotechnology Market
5. COMPETITOR ANALYSIS
5.1: Product Portfoli Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Animal Biotechnology Market by Product
7.1.2: Growth Opportunities for the Global Animal Biotechnology Market by Application
7.1.3: Growth Opportunities for the Global Animal Biotechnology Market by Animal Type
7.1.4: Growth Opportunities for the Global Animal Biotechnology Market by Region
7.2: Emerging Trends in the Global Animal Biotechnology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Animal Biotechnology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Animal Biotechnology Market
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Bayer AG
8.2: Merck & Co.
8.3: Pfizer
8.4: Boehringer Ingelheim
8.5: Virbac
8.6: Zoetis
8.7: Intervet
8.8: Santa Cruz Biotechnology, Inc.
8.9: Biogenesis Bag
8.10: Company
